Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2019

01-08-2019 | Magnetic Resonance Imaging | Case Report

Hepatic angiomyolipoma with early drainage veins into the hepatic and portal vein

Authors: Ryota Kiuchi, Takanori Sakaguchi, Ryo Kitajima, Satoru Furuhashi, Makoto Takeda, Takanori Hiraide, Yoshifumi Morita, Takasuke Ushio, Rei Ishikawa, Satoshi Baba, Hiroya Takeuchi

Published in: Clinical Journal of Gastroenterology | Issue 4/2019

Login to get access

Abstract

Hepatic angiomyolipoma (AML) is a rare stromal tumor composed of variable admixtures of thick-walled vessels, smooth muscles and adipose tissue. One of the specific radiological findings of hepatic AML is an early drainage vein noted via enhanced computed tomography (CT). We report a case of hepatic AML showing early drainage veins into both the hepatic and portal vein. The case involved a 46-year-old woman who was referred to our hospital because of a giant hepatic tumor. CT revealed well-enhanced 14 cm and 1 cm tumors in the left and right lobes, respectively. Magnetic resonance imaging demonstrated the existence of adipose tissues in the larger tumor. Hepatic arteriography revealed early drainage veins draining into both the hepatic and portal vein. Based on a diagnosis of hepatic AML, left hepatectomy and partial hepatectomy were performed. Pathology revealed both tumors as hepatic AML based on human melanoma black-45 immuno-positivity. Hepatic AML with early drainage veins into both the hepatic and portal vein is rare. The dilated and retrogressive vein drains the abundant arterial blood flow of the tumor. The finding of early drainage veins into not only the hepatic vein but also the portal vein should be helpful for diagnosing hepatic AMLs.
Literature
2.
go back to reference Ishak K. Mesenchymal tumors of the liver. In: Okuda K, Peters RL, editors. Hepatocellular carcinoma. New York: Wiley; 1976. pp. 228–304. Ishak K. Mesenchymal tumors of the liver. In: Okuda K, Peters RL, editors. Hepatocellular carcinoma. New York: Wiley; 1976. pp. 228–304.
3.
go back to reference Zheng RQ, Kudo M. Hepatic angiomyolipoma: identification of an efferent vessel to be hepatic vein by contrast-enhanced harmonic ultrasound. Br J Radiol. 2005;78:956–60.CrossRefPubMed Zheng RQ, Kudo M. Hepatic angiomyolipoma: identification of an efferent vessel to be hepatic vein by contrast-enhanced harmonic ultrasound. Br J Radiol. 2005;78:956–60.CrossRefPubMed
4.
go back to reference Jeon TY, Kim SH, Lim HK, et al. Assessment of triple-phase CT findings for the differentiation of fat-deficient hepatic angiomyolipoma from hepatocellular carcinoma in non-cirrhotic liver. Eur J Radiol. 2010;73:601–6.CrossRefPubMed Jeon TY, Kim SH, Lim HK, et al. Assessment of triple-phase CT findings for the differentiation of fat-deficient hepatic angiomyolipoma from hepatocellular carcinoma in non-cirrhotic liver. Eur J Radiol. 2010;73:601–6.CrossRefPubMed
5.
go back to reference Yoshioka M, Watanabe G, Uchinami H, et al. Hepatic angiomyolipoma: differential diagnosis from other liver tumors in a special reference to vascular imaging - importance of early drainage vein. Surg Case Rep. 2015;1:11.CrossRefPubMedPubMedCentral Yoshioka M, Watanabe G, Uchinami H, et al. Hepatic angiomyolipoma: differential diagnosis from other liver tumors in a special reference to vascular imaging - importance of early drainage vein. Surg Case Rep. 2015;1:11.CrossRefPubMedPubMedCentral
6.
go back to reference Saito Y, Shimada M, Utsunomiya T, et al. Hepatic epithelioid angiomyolipoma with arterioportal venous shunting mimicking hepatocellular carcinoma: report of a case. J Med Investig. 2013;60:262–6.CrossRef Saito Y, Shimada M, Utsunomiya T, et al. Hepatic epithelioid angiomyolipoma with arterioportal venous shunting mimicking hepatocellular carcinoma: report of a case. J Med Investig. 2013;60:262–6.CrossRef
7.
go back to reference Tsui WM, Colombari R, Portmann BC, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 1999;23:34–48.CrossRefPubMed Tsui WM, Colombari R, Portmann BC, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 1999;23:34–48.CrossRefPubMed
8.
go back to reference Martignoni G, Pea M, Reghellin D, et al. PEComas: the past, the present and the future. Virchows Arch. 2008;452:119–32.CrossRefPubMed Martignoni G, Pea M, Reghellin D, et al. PEComas: the past, the present and the future. Virchows Arch. 2008;452:119–32.CrossRefPubMed
9.
go back to reference Weeks DA, Malott RL, Arnesen M, et al. Hepatic angiomyolipoma with striated granules and positivity with melanoma–specific antibody (HMB-45): a report of two cases. Ultrastruct Pathol. 1991;15:563–71.CrossRefPubMed Weeks DA, Malott RL, Arnesen M, et al. Hepatic angiomyolipoma with striated granules and positivity with melanoma–specific antibody (HMB-45): a report of two cases. Ultrastruct Pathol. 1991;15:563–71.CrossRefPubMed
10.
go back to reference Makhlouf HR, Ishak KG, Shekar R, et al. Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study. Arch Pathol Lab Med. 2002;126:49–55.PubMed Makhlouf HR, Ishak KG, Shekar R, et al. Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study. Arch Pathol Lab Med. 2002;126:49–55.PubMed
11.
go back to reference Kudo M, Okuno T, Tomita S, et al. Hepatic angiomyolipoma pre-operatively diagnosed by imaging. J Gastroenterol Hepatol. 1993;8:483–8.CrossRefPubMed Kudo M, Okuno T, Tomita S, et al. Hepatic angiomyolipoma pre-operatively diagnosed by imaging. J Gastroenterol Hepatol. 1993;8:483–8.CrossRefPubMed
12.
go back to reference Ahmadi T, Itai Y, Takahashi M, et al. Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging. 1998;23:520–6.CrossRefPubMed Ahmadi T, Itai Y, Takahashi M, et al. Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging. 1998;23:520–6.CrossRefPubMed
13.
go back to reference Yan F, Zeng M, Zhou K, et al. Hepatic angiomyolipoma: various appearances on two-phase contrast scanning of spiral CT. Eur J Radiol. 2002;41:12–8.CrossRefPubMed Yan F, Zeng M, Zhou K, et al. Hepatic angiomyolipoma: various appearances on two-phase contrast scanning of spiral CT. Eur J Radiol. 2002;41:12–8.CrossRefPubMed
14.
go back to reference Yoshimura H, Murakami T, Kim T, et al. Angiomyolipoma of the liver with least amount of fat component: imaging features of CT, MR, and angiography. Abdom Imaging. 2002;27:184–7.CrossRefPubMed Yoshimura H, Murakami T, Kim T, et al. Angiomyolipoma of the liver with least amount of fat component: imaging features of CT, MR, and angiography. Abdom Imaging. 2002;27:184–7.CrossRefPubMed
15.
go back to reference Wang S, Kuai X, Meng X, et al. Comparison of MRI features for the differentiation of hepatic angiomyolipoma from fat-containing hepatocellular carcinoma. Abdom Imaging. 2014;39:323–33.CrossRefPubMed Wang S, Kuai X, Meng X, et al. Comparison of MRI features for the differentiation of hepatic angiomyolipoma from fat-containing hepatocellular carcinoma. Abdom Imaging. 2014;39:323–33.CrossRefPubMed
16.
go back to reference Iwao Y, Ojima H, Onaya H, et al. Early venous return in hepatic angiomyolipoma due to an intratumoral structure resembling an arteriovenous fistula. Hepatol Res. 2014;44:700–6.CrossRefPubMed Iwao Y, Ojima H, Onaya H, et al. Early venous return in hepatic angiomyolipoma due to an intratumoral structure resembling an arteriovenous fistula. Hepatol Res. 2014;44:700–6.CrossRefPubMed
17.
go back to reference Murakami T, Nakamura H, Hori S, et al. Angiomyolipoma of the liver. Ultrasound, CT, MR imaging and angiography. Acta Radiol. 1993;34:392–4.CrossRefPubMed Murakami T, Nakamura H, Hori S, et al. Angiomyolipoma of the liver. Ultrasound, CT, MR imaging and angiography. Acta Radiol. 1993;34:392–4.CrossRefPubMed
18.
go back to reference Dalle I, Sciot R, de Vos R, et al. Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology. 2000;36:443–50.CrossRefPubMed Dalle I, Sciot R, de Vos R, et al. Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology. 2000;36:443–50.CrossRefPubMed
19.
go back to reference Mizuguchi T, Katsuramaki T, Nobuoka T, et al. Growth of hepatic angiomyolipoma indicating malignant potential. J Gastroenterol Hepatol. 2004;19:1328–30.CrossRefPubMed Mizuguchi T, Katsuramaki T, Nobuoka T, et al. Growth of hepatic angiomyolipoma indicating malignant potential. J Gastroenterol Hepatol. 2004;19:1328–30.CrossRefPubMed
20.
go back to reference Deng YF, Lin Q, Zhang SH, et al. Malignant angiomyolipoma in the liver: a case report with pathological and molecular analysis. Pathol Res Pract. 2008;204:911–8.CrossRefPubMed Deng YF, Lin Q, Zhang SH, et al. Malignant angiomyolipoma in the liver: a case report with pathological and molecular analysis. Pathol Res Pract. 2008;204:911–8.CrossRefPubMed
21.
go back to reference Nguyen TT, Gorman B, Shields D, et al. Malignant hepatic angiomyolipoma: report of a case and review of literature. Am J Surg Pathol. 2008;32:793–8.CrossRefPubMed Nguyen TT, Gorman B, Shields D, et al. Malignant hepatic angiomyolipoma: report of a case and review of literature. Am J Surg Pathol. 2008;32:793–8.CrossRefPubMed
22.
go back to reference Kamimura K, Oosaki A, Sugahara S, et al. Malignant potential of hepatic angiomyolipoma: case report and literature review. Clin J Gastroenterol. 2010;3:104–10.CrossRefPubMed Kamimura K, Oosaki A, Sugahara S, et al. Malignant potential of hepatic angiomyolipoma: case report and literature review. Clin J Gastroenterol. 2010;3:104–10.CrossRefPubMed
23.
go back to reference Fukuda Y, Omiya H, Takami K, et al. Malignant hepatic epithelioid angiomyolipoma with recurrence in the lung 7 years after hepatectomy: a case report and literature review. Surg Case Rep. 2016;2:31.CrossRefPubMedPubMedCentral Fukuda Y, Omiya H, Takami K, et al. Malignant hepatic epithelioid angiomyolipoma with recurrence in the lung 7 years after hepatectomy: a case report and literature review. Surg Case Rep. 2016;2:31.CrossRefPubMedPubMedCentral
24.
go back to reference Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol. 2002;26:493–7.CrossRefPubMed Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol. 2002;26:493–7.CrossRefPubMed
25.
go back to reference Parfitt JR, Bella AJ, Izawa JI, et al. Malignant neoplasm of perivascular epithelioid cells of the liver. Arch Pathol Lab Med. 2006;130:1219–22.PubMed Parfitt JR, Bella AJ, Izawa JI, et al. Malignant neoplasm of perivascular epithelioid cells of the liver. Arch Pathol Lab Med. 2006;130:1219–22.PubMed
26.
go back to reference Folpe AL, Mentzel T, Lehr H-AA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29:1558–75.CrossRefPubMed Folpe AL, Mentzel T, Lehr H-AA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29:1558–75.CrossRefPubMed
Metadata
Title
Hepatic angiomyolipoma with early drainage veins into the hepatic and portal vein
Authors
Ryota Kiuchi
Takanori Sakaguchi
Ryo Kitajima
Satoru Furuhashi
Makoto Takeda
Takanori Hiraide
Yoshifumi Morita
Takasuke Ushio
Rei Ishikawa
Satoshi Baba
Hiroya Takeuchi
Publication date
01-08-2019
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 4/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-00946-2

Other articles of this Issue 4/2019

Clinical Journal of Gastroenterology 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.